AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Shineco, Inc. engages in processing and distributing specialized fabrics, textiles, and other byproducts derived from an indigenous Chinese plant Apocynum Venetum in the People's Republic of China.
The company's specialized fabrics, textiles, and other byproducts are specialized textile and health supplement products to incorporate traditional Eastern medicines with various scientific methods.
It also grows and cultivates yew trees, fast-growing bamboo willows, and scenic greening trees; and provides logistic services for agricultural products.
The company is headquartered in Beijing, the People's Republic of China.
Country | CN |
IPO Date | Sep 28, 2016 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 119 |
CEO | Jennifer Zhan |
Contact Details
Address: North Tower, Zhengda Center Beijing, CN | |
Website | https://www.biosisi.com |
Stock Details
Ticker Symbol | SISI |
Exchange | NASDAQ |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | 0001300734 |
CUSIP Number | 824567309 |
ISIN Number | US8245674085 |
Employer ID | 52-2175898 |
SIC Code | 0100 |
Key Executives
Name | Position |
---|---|
Jennifer Zhan | Chief Executive Officer & Executive Director |
Sai Wang | Chief Financial Officer & Director |
Xiqiao Liu | Chief Operating Officer & Executive Director |
Chi Keung Yan | Chief Strategy Officer |
Dr. Fenming Liu | Chief Scientist |
Qiyin Sun | Chief Medical Consultant |
Wang Xiaohui | Executive President |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 14, 2025 | S-3 | Filing |
Dec 30, 2024 | 8-K | Current Report |
Dec 09, 2024 | 8-K | Current Report |
Dec 04, 2024 | 8-K | Current Report |
Nov 14, 2024 | 10-Q | Quarterly Report |
Nov 12, 2024 | 8-K | Current Report |
Nov 08, 2024 | 8-K | Current Report |
Oct 25, 2024 | 8-K | Current Report |
Oct 25, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oct 04, 2024 | DEF 14A | Filing |